FDA’s New Guidance for Industry Addressing Evaluation of the Safety of New Drugs for Improving Glycemic Control: A Case Study in Regulatory Science
J. Rick Turner
Topics & Concepts
Regulatory sciencePharmacyGlycemicPharmacologyMedicineRisk analysis (engineering)Diabetes mellitusFamily medicineEndocrinologyPathologyDiabetes Treatment and ManagementDiabetes Management and ResearchPharmacology and Obesity Treatment